tradingkey.logo
搜索

Sonoma Pharmaceuticals Inc

SNOA
添加自选
1.210USD
0.0000.00%
收盘 07/02, 13:00美东报价延迟15分钟
2.18M总市值
亏损市盈率 TTM

Sonoma Pharmaceuticals Inc

1.210
0.0000.00%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

+8.04%

1月

0.00%

6月

-66.76%

今年开始到现在

-66.76%

1年

-59.26%

关键数据
1.220今开
1.225最高
60.65K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
3.37%换手率
1.210昨收
1.190最低
62.86K成交额
亏损市盈率静
0.70市净率
0.00%股息率 TTM
-24.70%ROA
6.92052周最高
0.42量比
-3.46M净利润
1.80M总股本
-1.9416每股收益TTM
1.29Beta
-81.19%ROE
0.85052周最低
2.89%振幅
39.22%毛利率
2.18M总市值
--回报/风险
4.46%风险率

TradingKey Sonoma Pharmaceuticals Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Sonoma Pharmaceuticals Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在药品行业排名126/157位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价14.80。中期看,股价处于下降通道。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Sonoma Pharmaceuticals Inc评分

相关信息

行业排名
126 / 157
全市场排名
433 / 4565
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Sonoma Pharmaceuticals Inc亮点

亮点风险
Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
业绩高增长
公司营业收入稳步增长,连续3年增长53.35%
业绩增长期
公司处于发展阶段,最新年度总收入19.53M美元
估值合理
公司最新PE估值-0.62,处于3年历史合理位
机构减仓
最新机构持股127.80K股,环比减少21.35%

分析师目标

根据 0 位分析师
--
评级
14.800
目标均价
+1198.25%
涨幅空间

Sonoma Pharmaceuticals Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Sonoma Pharmaceuticals Inc简介

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
公司代码SNOA
公司Sonoma Pharmaceuticals Inc
CEOTrombly (Amy)
网址https://sonomapharma.com/

常见问题

Sonoma Pharmaceuticals Inc(SNOA)的当前股价是多少?

Sonoma Pharmaceuticals Inc(SNOA)的当前股价是 1.21。

Sonoma Pharmaceuticals Inc的股票代码是什么?

Sonoma Pharmaceuticals Inc的股票代码是SNOA。

Sonoma Pharmaceuticals Inc股票的52周最高点是多少?

Sonoma Pharmaceuticals Inc股票的52周最高点是6.92。

Sonoma Pharmaceuticals Inc股票的52周最低点是多少?

Sonoma Pharmaceuticals Inc股票的52周最低点是0.85。

Sonoma Pharmaceuticals Inc的市值是多少?

Sonoma Pharmaceuticals Inc的市值是2.18M。

Sonoma Pharmaceuticals Inc(SNOA)股票的每股收益(EPS TTM)是多少

Sonoma Pharmaceuticals Inc(SNOA)股票的每股收益(EPS TTM)是-1.89。